Nanoparticle albumin-bound paclitaxel for metastatic breast cancer

被引：68
|
作者：
Harries, M [1 ]
Ellis, P [1 ]
Harper, P [1 ]
机构：
[1] Guys & St Thomas Hosp, Dept Med Oncol, London SE1 9RT, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 31期
关键词：
D O I：
10.1200/JCO.2005.08.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7768 / 7771
页数：4
相关论文
共 50 条
  • [41] Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer
    Zhang, Changhua
    Awasthi, Niranjan
    Schwarz, Margaret A.
    Hinz, Stefan
    Schwarz, Roderich E.
    PLOS ONE, 2013, 8 (02):
  • [42] Superior Antitumor Activity of Nanoparticle Albumin-Bound Paclitaxel in Experimental Gastric Cancer
    Zhang, C.
    Ostapoff, K. T.
    Awasthi, N.
    Schwarz, M. A.
    Schwarz, R. E.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S136 - S137
  • [43] Preclinical Investigation of Nanoparticle Albumin-Bound Paclitaxel as a Potential Treatment for Adrenocortical Cancer
    Demeure, Michael J.
    Stephan, Elizabeth
    Sinari, Shripad
    Mount, David
    Gately, Steven
    Gonzales, Paul
    Hostetter, Galen
    Komorowski, Richard
    Kiefer, Jeff
    Grant, Clive S.
    Han, Haiyong
    von Hoff, Daniel D.
    Bussey, Kimberly J.
    ANNALS OF SURGERY, 2012, 255 (01) : 140 - 146
  • [44] Cost-effectiveness of nanoparticle albumin-bound (nab) paclitaxel (ABX) vs Cremophor-based paclitaxel (CP) in the treatment of metastatic breast cancer (MBC).
    Gradishar, W
    Wolinsky, S
    Vishalpura, T
    Nightengale, B
    Bramley, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 36S - 36S
  • [45] Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer
    Masashi Ando
    Kan Yonemori
    Noriyuki Katsumata
    Chikako Shimizu
    Taizo Hirata
    Harukaze Yamamoto
    Kenji Hashimoto
    Mayu Yunokawa
    Kenji Tamura
    Yasuhiro Fujiwara
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 457 - 465
  • [46] Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer
    Ando, Masashi
    Yonemori, Kan
    Katsumata, Noriyuki
    Shimizu, Chikako
    Hirata, Taizo
    Yamamoto, Harukaze
    Hashimoto, Kenji
    Yunokawa, Mayu
    Tamura, Kenji
    Fujiwara, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 457 - 465
  • [47] Dose-dense nab-paclitaxel (nanoparticle albumin-bound paclitaxel) in adjuvant chemotherapy for breast cancer: A feasibility study
    Burstein, H. J.
    Mayer, E. L.
    Peppercorn, J.
    Parker, L. M.
    Hannagan, K.
    Moy, B.
    Younger, J.
    Schapira, L.
    Wulf, G.
    Gelman, R.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Safety of nanoparticle albumin-bound paclitaxel administered to breast cancer patients with clinical contraindications to paclitaxel or docetaxel: Four case reports
    Kimura, Kosei
    Tanaka, Satoru
    Iwamoto, Mitsuhiko
    Fujioka, Hiroya
    Takahashi, Yuko
    Sato, Nayuko
    Terasawa, Risa
    Tominaga, Tomo
    Ikari, Ayana
    Uchiyama, Kazuhisa
    ONCOLOGY LETTERS, 2013, 6 (04) : 881 - 884
  • [49] Albumin-Bound Paclitaxel In Metastatic Breast CancerA Viewpoint by Mark Harries and Peter Harper
    Mark Harries
    Peter Harper
    Drugs, 2006, 66 (7) : 949 - 949
  • [50] Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer
    Yang, Miaomiao
    Qu, Huajun
    Liu, Aina
    Liu, Jiannan
    Sun, Ping
    Li, Hua
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (07) : 1561 - 1566
12345